Table 1. Human Rabies Vaccine (Vero Cell) Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Human Rabies Vaccine (Vero Cell) Market Restraints

Table 3. Human Rabies Vaccine (Vero Cell) Market Trends

Table 4. Human Rabies Vaccine (Vero Cell) Industry Policy

Table 5. Global Human Rabies Vaccine (Vero Cell) Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Human Rabies Vaccine (Vero Cell) Revenue Share by Company, 2018-2023, Ranked by Data of 2022

Table 7. Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 8. Global Human Rabies Vaccine (Vero Cell) Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 9. Global Human Rabies Vaccine (Vero Cell) Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)

Table 10. Global Human Rabies Vaccine (Vero Cell) Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Human Rabies Vaccine (Vero Cell) Mergers & Acquisitions, Expansion Plans

Table 12. Global Human Rabies Vaccine (Vero Cell) Manufacturers Product Type

Table 13. Head Office and Human Rabies Vaccine (Vero Cell) Production Site of Key Manufacturer

Table 14. Human Rabies Vaccine (Vero Cell) Capacity of Major Manufacturers and Future Plan

Table 15. China Human Rabies Vaccine (Vero Cell) Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 16. China Human Rabies Vaccine (Vero Cell) Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 17. China Human Rabies Vaccine (Vero Cell) Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 18. Global Human Rabies Vaccine (Vero Cell) Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 19. Global Human Rabies Vaccine (Vero Cell) Production by Region, 2018-2023, (K Units)

Table 20. Global Human Rabies Vaccine (Vero Cell) Production Forecast by Region, 2024-2029, (K Units)

Table 21. Global Key Players of Human Rabies Vaccine (Vero Cell) Upstream (Raw Materials)

Table 22. Global Human Rabies Vaccine (Vero Cell) Typical Customers

Table 23. Human Rabies Vaccine (Vero Cell) Typical Distributors

Table 24. By Type, Global Human Rabies Vaccine (Vero Cell) Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 25. By Application, Global Human Rabies Vaccine (Vero Cell) Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 26. By Region, Global Human Rabies Vaccine (Vero Cell) Consumption Value, 2018 VS 2022 VS 2029, US$ Million

Table 27. By Region, Global Human Rabies Vaccine (Vero Cell) Consumption Value, 2018-2029, US$ Million

Table 28. By Region, Global Human Rabies Vaccine (Vero Cell) Sales Quantity, 2018-2029, (K Units)

Table 29. By Country, Global Human Rabies Vaccine (Vero Cell) Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Country, Global Human Rabies Vaccine (Vero Cell) Consumption Value, 2018-2029, US$ Million

Table 31. By Country, Global Human Rabies Vaccine (Vero Cell) Consumption Value Market Share, 2018-2029

Table 32. By Country, Global Human Rabies Vaccine (Vero Cell) Sales Quantity, 2018-2029, (K Units)

Table 33. By Country, Global Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share, 2018-2029

Table 34. Liaoning Chengda Company Information, Head Office, Market Area, and Industry Position

Table 35. Liaoning Chengda Human Rabies Vaccine (Vero Cell) Models, Specifications, and Application

Table 36. Liaoning Chengda Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 37. Liaoning Chengda Company Profile and Main Business

Table 38. Liaoning Chengda Recent Developments

Table 39. Guangzhou Nuocheng Company Information, Head Office, Market Area, and Industry Position

Table 40. Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Models, Specifications, and Application

Table 41. Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Guangzhou Nuocheng Company Profile and Main Business

Table 43. Guangzhou Nuocheng Recent Developments

Table 44. Ningbo Rong'an Company Information, Head Office, Market Area, and Industry Position

Table 45. Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Models, Specifications, and Application

Table 46. Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Ningbo Rong'an Company Profile and Main Business

Table 48. Ningbo Rong'an Recent Developments

Table 49. Hualan Bio-vaccine Company Information, Head Office, Market Area, and Industry Position

Table 50. Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Models, Specifications, and Application

Table 51. Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Hualan Bio-vaccine Company Profile and Main Business

Table 53. Hualan Bio-vaccine Recent Developments

Table 54. Sanofi Pasteur SA Company Information, Head Office, Market Area, and Industry Position

Table 55. Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Models, Specifications, and Application

Table 56. Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Sanofi Pasteur SA Company Profile and Main Business

Table 58. Sanofi Pasteur SA Recent Developments

Table 59. Bharat Biotech Company Information, Head Office, Market Area, and Industry Position

Table 60. Bharat Biotech Human Rabies Vaccine (Vero Cell) Models, Specifications, and Application

Table 61. Bharat Biotech Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Bharat Biotech Company Profile and Main Business

Table 63. Bharat Biotech Recent Developments

Table 64. Bavarian Nordic Company Information, Head Office, Market Area, and Industry Position

Table 65. Bavarian Nordic Human Rabies Vaccine (Vero Cell) Models, Specifications, and Application

Table 66. Bavarian Nordic Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Bavarian Nordic Company Profile and Main Business

Table 68. Bavarian Nordic Recent Developments

Table 69. Serum Institute of India Pvt. Company Information, Head Office, Market Area, and Industry Position

Table 70. Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Models, Specifications, and Application

Table 71. Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Serum Institute of India Pvt. Company Profile and Main Business

Table 73. Serum Institute of India Pvt. Recent Developments

Table 74. Chengdu Kanghua Biology Company Information, Head Office, Market Area, and Industry Position

Table 75. Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Models, Specifications, and Application

Table 76. Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Chengdu Kanghua Biology Company Profile and Main Business

Table 78. Chengdu Kanghua Biology Recent Developments

Table 79. Changchun Zhuoyi Biology Company Information, Head Office, Market Area, and Industry Position

Table 80. Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Models, Specifications, and Application

Table 81. Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Changchun Zhuoyi Biology Company Profile and Main Business

Table 83. Changchun Zhuoyi Biology Recent Developments

Table 84. Dalian Yali Peak Company Information, Head Office, Market Area, and Industry Position

Table 85. Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Models, Specifications, and Application

Table 86. Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 87. Dalian Yali Peak Company Profile and Main Business

Table 88. Dalian Yali Peak Recent Developments

Table 89. Jilin Huikang Biopharmaceutical Co., Ltd. Company Information, Head Office, Market Area, and Industry Position

Table 90. Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Models, Specifications, and Application

Table 91. Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 92. Jilin Huikang Biopharmaceutical Co., Ltd. Company Profile and Main Business

Table 93. Jilin Huikang Biopharmaceutical Co., Ltd. Recent Developments

List of Figures

Figure 1. Human Rabies Vaccine (Vero Cell) Picture

Figure 2. Global Human Rabies Vaccine (Vero Cell) Consumption Value, (US$ million) & (2018-2029)

Figure 3. Global Human Rabies Vaccine (Vero Cell) Sales Quantity, (K Units) & (2018-2029)

Figure 4. Global Human Rabies Vaccine (Vero Cell) Average Selling Price (ASP), (2018-2029) & (US$/Unit)

Figure 5. China Human Rabies Vaccine (Vero Cell) Consumption Value, (US$ million) & (2018-2029)

Figure 6. China Human Rabies Vaccine (Vero Cell) Sales Quantity (K Units) & (2018-2029)

Figure 7. China Human Rabies Vaccine (Vero Cell) Average Selling Price (ASP), (US$/Unit) & (2018-2029)

Figure 8. By Consumption Value, China Human Rabies Vaccine (Vero Cell) Market Share of Global, 2018-2029

Figure 9. By Sales Quantity, China Human Rabies Vaccine (Vero Cell) Market Share of Global, 2018-2029

Figure 10. Global Human Rabies Vaccine (Vero Cell) Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 11. China Human Rabies Vaccine (Vero Cell) Key Participants, Market Share, 2022

Figure 12. Global Human Rabies Vaccine (Vero Cell) Capacity, Production and Capacity Utilization, 2018-2029

Figure 13. Global Human Rabies Vaccine (Vero Cell) Capacity Market Share by Region, 2022 VS 2029

Figure 14. Global Human Rabies Vaccine (Vero Cell) Production Market Share & Forecast by Region, 2018-2029

Figure 15. Human Rabies Vaccine (Vero Cell) Industry Chain

Figure 16. Human Rabies Vaccine (Vero Cell) Procurement Model

Figure 17. Human Rabies Vaccine (Vero Cell) Sales Model

Figure 18. Human Rabies Vaccine (Vero Cell) Sales Channels, Direct Sales, and Distribution

Figure 19. 0.5ml

Figure 20. 1ml

Figure 21. By Type, Global Human Rabies Vaccine (Vero Cell) Consumption Value, 2018-2029, US$ Million

Figure 22. By Type, Global Human Rabies Vaccine (Vero Cell) Consumption Value Market Share, 2018-2029

Figure 23. By Type, Global Human Rabies Vaccine (Vero Cell) Sales Quantity, 2018-2029, (K Units)

Figure 24. By Type, Global Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share, 2018-2029

Figure 25. By Type, Global Human Rabies Vaccine (Vero Cell) Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 26. Hospital

Figure 27. Clinic

Figure 28. By Application, Global Human Rabies Vaccine (Vero Cell) Consumption Value, 2018-2029, US$ Million

Figure 29. By Application, Global Human Rabies Vaccine (Vero Cell) Consumption Value Market Share, 2018-2029

Figure 30. By Application, Global Human Rabies Vaccine (Vero Cell) Sales Quantity, 2018-2029, (K Units)

Figure 31. By Application, Global Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share, 2018-2029

Figure 32. By Application, Global Human Rabies Vaccine (Vero Cell) Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 33. By Region, Global Human Rabies Vaccine (Vero Cell) Consumption Value Market Share, 2018-2029

Figure 34. By Region, Global Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share, 2018-2029

Figure 35. North America Human Rabies Vaccine (Vero Cell) Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 36. By Country, North America Human Rabies Vaccine (Vero Cell) Consumption Value Market Share, 2022

Figure 37. Europe Human Rabies Vaccine (Vero Cell) Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 38. By Country, Europe Human Rabies Vaccine (Vero Cell) Consumption Value Market Share, 2022

Figure 39. Asia Pacific Human Rabies Vaccine (Vero Cell) Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 40. By Country/Region, Asia Pacific Human Rabies Vaccine (Vero Cell) Consumption Value Market Share, 2022

Figure 41. South America Human Rabies Vaccine (Vero Cell) Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 42. By Country, South America Human Rabies Vaccine (Vero Cell) Consumption Value Market Share, 2022

Figure 43. Middle East & Africa Human Rabies Vaccine (Vero Cell) Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 44. U.S. Human Rabies Vaccine (Vero Cell) Sales Quantity, 2018-2029, (K Units)

Figure 45. By Type, U.S. Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share, 2022 VS 2029

Figure 46. By Application, U.S. Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share, 2022 VS 2029

Figure 47. Europe Human Rabies Vaccine (Vero Cell) Sales Quantity, 2018-2029, (K Units)

Figure 48. By Type, Europe Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share, 2022 VS 2029

Figure 49. By Application, Europe Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share, 2022 VS 2029

Figure 50. China Human Rabies Vaccine (Vero Cell) Sales Quantity, 2018-2029, (K Units)

Figure 51. By Type, China Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share, 2022 VS 2029

Figure 52. By Application, China Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share, 2022 VS 2029

Figure 53. Japan Human Rabies Vaccine (Vero Cell) Sales Quantity, 2018-2029, (K Units)

Figure 54. By Type, Japan Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share, 2022 VS 2029

Figure 55. By Application, Japan Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share, 2022 VS 2029

Figure 56. South Korea Human Rabies Vaccine (Vero Cell) Sales Quantity, 2018-2029, (K Units)

Figure 57. By Type, South Korea Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share, 2022 VS 2029

Figure 58. By Application, South Korea Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share, 2022 VS 2029

Figure 59. Southeast Asia Human Rabies Vaccine (Vero Cell) Sales Quantity, 2018-2029, (K Units)

Figure 60. By Type, Southeast Asia Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share, 2022 VS 2029

Figure 61. By Application, Southeast Asia Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share, 2022 VS 2029

Figure 62. India Human Rabies Vaccine (Vero Cell) Sales Quantity, 2018-2029, (K Units)

Figure 63. By Type, India Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share, 2022 VS 2029

Figure 64. By Application, India Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share, 2022 VS 2029

Figure 65. Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity, 2018-2029, (K Units)

Figure 66. By Type, Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share, 2022 VS 2029

Figure 67. By Application, Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales Quantity Market Share, 2022 VS 2029

Figure 68. Research Methodology

Figure 69. Breakdown of Primary Interviews

Figure 70. Bottom-up and Top-down Approaches

Figure 71. Top-down Approaches